Ventricular Assist Devices Market Analysis

End-user (Specialty Clinics, Hospitals, ASCs)

The global ventricular assist devices market is segmented and analyzed for demand and supply by end-user into specialty clinics, hospitals, ASCs, and others, out of which, the hospitals segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted for by the mounting patient pool in hospitals over the recent decades, the increasing number of hospitalization days, and the growing number of physicians in developing and low-income countries. As of 2018, it was observed that approximately 100 million people visited the emergency department.

Our in-depth analysis of the global market includes the following segments:

By Product Type	Biventricular Assist Devices (BIVADs) Right Ventricular Assist Devices (RVADs) Left Ventricular (LVADs)
By Design	Implantable Transcutaneous Ventricular Assist Devices
By Application	Bridge-to-Transplant (BTT) Bridge-to-Candidacy (BTC) Bridge-to-Transplant (BTT) Destination Therapy
By End-User	Specialty Clinics Hospitals ASCs Others

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of ventricular assist devices is estimated at USD 2.98 billion.

The ventricular assist devices market size was valued at USD 2.77 billion in 2024 and is poised to cross USD 8.96 billion by the end of 2037, expanding at more than 9.4% CAGR during the forecast period i.e., between 2025-2037. Rising penetration of stroke and increasing prevalence of coronary artery disease will drive the market growth.

North America industry is predicted to hold largest revenue share by 2037, driven by increasing cases of cardiac arrests along with rising adoption of new technological devices, and growing agreements for collaborations and development by the key players in the region.

The major players in the market include Abbott Laboratories, Sun Medical Technology Research CorpÃƒÂ¯Ã‚Â¼Ãƒâ€¦Ã‚Â½, Berlin Heart GmbH, Abiomed, Inc., ReliantHeart, Inc., Jarvik Heart, Inc, LivaNova, Inc., Boston Scientific Corporation, Calon cardio-Technology Ltd., Medtronic plc.

Ventricular Assist Devices Market Analysis